Biogen Set For Avonex Launch In India, But Concerned About Biosimilars Regulations
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Big Pharma has been increasingly attracted to the Indian market, but now big biotechs like Biogen Idec are also expanding their presence to make the most of the growth opportunities